✦ LIBER ✦

Feasibility study comparing docetaxel–cisplatin versus docetaxel–carboplatin as first-line chemotherapy for ovarian cancer

✍ Scribed by Yukihisa Minagawa; Junzo Kigawa; Yasunobu Kanamori; Hiroaki Itamochi; Naoki Terakawa; Makoto Okada; Fuminori Kitada

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SCOTROC 2A: Carboplatin followed by doce

✍ Vasey, P A; Atkinson, R; Osborne, R; Parkin, D; Symonds, R; Paul, J; Lewsley, L; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 142 KB

SCOTROC 2B: feasibility of carboplatin f

✍ Clamp, A R; Mäenpää, J; Cruickshank, D; Ledermann, J; Wilkinson, P M; Welch, R; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

A dose finding study of docetaxel/carbop

✍ R. Atkinson; P.A. Vasey; R. Coleman; M. Crawford; M. Cruickshank; P. Eggleton; D 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Docetaxel (D) and carboplatin with Auc-7

✍ Mehrdad Salimi; Manuchehr Davaee 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 150 KB

P-452 Phase III study of docetaxel-cispl

✍ Belani, C.; von Pawel, J.; Pluzanska, A.; Gorbounova, V.; Kaukel, E.; Mattson, K 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 145 KB

A phase II study of sequential docetaxel

✍ Eleni M. Karapanagiotou; Adrianni Charpidou; Ifigenia Tzannou; Kalliopi Dilana; 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 159 KB